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Application of Default Rules to Address Financial Conflicts 
of Interest in Academic Medical Centers 
JOANNA K. SAX
*
 
A recent report issued from the Institute of Medicine contains an extensive 
analysis of financial conflicts of interest (FCOIs) in biomedical science.
1
 In brief, 
an FCOI exists when a profit-seeking motive either unduly influences or appears to 
influence an academic scientist’s primary obligations.2 The cornerstone of current 
policy to address FCOIs at academic medical centers (AMCs) is disclosure; 
however, disclosure does not appear to appropriately regulate, manage, or eliminate 
FCOIs.  
Interestingly, the regulation of FCOIs for extramural scientists (those who 
conduct research at AMCs) is quite different than the rules that apply to intramural 
scientists (those who conduct research within the National Institutes of Health 
(NIH)). Policies that regulate extramural scientists tend to focus on disclosure, 
either to the university or to the granting agency that is funding the research in a 
particular laboratory. The policies that govern intramural scientists contain defined 
restrictions on the types of relationships that the government scientists can have 
with the private sector. Although extramural and intramural scientists exist in 
somewhat different environments, an analysis of the impact of the NIH guidelines 
for intramural scientists over the past several years may provide valuable 
information for the types of rules that could be applied to extramural scientists to 
address FCOIs at medical schools. Medical schools struggle to regulate this area, 
and the application of a set of default rules applied to all AMCs may assist in 
decreasing or eliminating the detrimental impact of FCOIs.
3
 
Intramural scientists are employees of the federal government and they conduct 
research at the NIH. Intramural scientists receive government funding to support 
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their laboratories. They do not apply for grants to obtain funding, but they do 
undergo a review process.
4
 Extramural scientists are employed by AMCs, usually 
within a larger university. Extramural scientists apply for grants to fund their 
laboratories. Although multiple sources of funding may exist, the NIH is the largest 
agency that supports biomedical research.
5
  
Intramural scientists interact with the private sector in a number of ways. For 
example, intramural scientists may be asked to serve as advisors to a private 
company. Intramural scientists may be asked to give presentations by outside 
companies or researchers in exchange for compensation.
6
 This interaction with the 
private sector may create an FCOI if, for example, a private company applies to 
work with the NIH on a particular project. If an intramural scientist has a 
relationship with a private company and that intramural scientist is in a decision-
making position with respect to the private company’s request, the scientist may 
favor the company’s request.  
Extramural scientists interact with the private sector in ways that may be the 
same or different than intramural scientists. An extramural scientist may obtain 
funding from a private company to support their research. This type of interaction 
is increasing for a number of reasons including: (1) a decrease in the amount of 
government support and (2) incentives for public-private relationships created 
through the Bayh-Dole Act of 1980.
7
 The extramural scientist may face an FCOI 
created by terms in the contract with the private company, such as delay of 
publication of results, or the extramural scientist may yield to pressure by a private 
funding source to present data in a favorable light in order to continue receiving 
funding from the private company.
8
 
Although the relationships between intramural scientists and industry and 
extramural scientists and industry may be structurally different, they both can lead 
to FCOIs that threaten scientific integrity. Overall, the NIH policies governing 
FCOIs for intramural scientists are much stricter than those applied in AMCs. This 
Essay proposes that the NIH policies for intramural scientists can be used as a 
template to create default rules in AMCs that govern the extramural scientist-
private company relationship.  
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I. SIMILARITIES AND DIFFERENCES BETWEEN INTRAMURAL  
AND EXTRAMURAL SCIENTISTS 
Intramural and extramural scientists share many similarities including exercising 
intellectual freedom, receiving government support, researching issues in basic 
science, and conducting clinical trials. Both intramural and extramural scientists 
have the same objectives to relieve pain and suffering and to contribute research 
that benefits the public. Many scientists who choose to enter academics or take a 
position at the NIH could work in the private sector (for more money), but choose 
academics or the NIH because of the freedom of intellectual curiosity and personal 
ambitions. Both intramural and extramural scientists tend to have nontangible goals 
including enhancement of reputation and career advancement that come as a result 
of their hard work and accomplishments.
9
 
The funding structure for intramural and extramural scientists is different. 
Intramural scientists are allocated resources for research and undergo a review 
every four years.
10
 Extramural scientists apply to the NIH through a grant system.
11
 
The NIH has a limited amount of money that it can use to fund grant applications; 
thus, the grant process is highly competitive. 
Other differences include the types of employment packages. For example, 
intramural scientists are federal employees, and they receive federal benefits. 
Extramural scientists are employees of AMCs and receive benefits from the 
university—although grant money is often used to pay for their benefits.12 
Some might say that the research conducted at the NIH is riskier (i.e., it has a 
low likelihood of success), but if successful, the pay-off is high.
13
 This may be 
because of the resources available to intramural scientists on the NIH campus as 
well as the goals of the NIH. Extramural scientists might be less likely to conduct 
high-risk research because it is harder for them to obtain grant money and because 
resources at their home campuses may be limited. Although there may be some 
truth to this assertion, many great discoveries come from academic laboratories, so 
it is difficult to determine the validity of this argument. 
The overall characteristics between intramural and extramural scientists are 
quite similar. Many scientists move between academics and the NIH. Both 
                                                                                                                 
 
 9. See David Korn, Conflicts of Interest in Biomedical Research, 284 JAMA 2234, 
2234 (2000). 
 10. NIH INTRAMURAL RESEARCH, supra note 4, at 16 (“As a result of these reviews, 
recommendations for altering allocated resources are made to the Scientific Director, the 
Institute or Center Director, the NIH Deputy Director for Intramural Research, and the 
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 11. Grant Review Process, NAT’L INSTS. HEALTH (Mar. 20, 2008), 
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vast and advanced technology infrastructure . . . .”). 
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scientists face circumstances that allow them to interact with the private sector, yet 
these interactions are regulated quite differently depending on whether the scientist 
is intramural or extramural. Because both types of scientists receive federal grant 
money to conduct research and have the same goal of understanding and treating 
diseases, a goal that benefits the public, these two sets of scientists should be 
subject to the same FCOI rules. Intramural scientists have strict rules regarding 
holdings of securities and financial compensation for consulting, lectures, and 
awards. Extramural scientists, on the other hand, are largely governed by rules that 
focus on disclosure.  
II. FINANCIAL CONFLICT OF INTEREST RULES WITHIN THE NIH 
In 2005, the NIH instituted a set of rules that changed the financial relationships 
of its intramural scientists with the private sector. Under these rules, intramural 
scientists were required to divest, file disclosures on, and eliminate employment 
with substantially affected organizations (SAOs), and limit compensation through 
awards or gifts.
14
  
A. History of Conflict of Interest Rules at the NIH 
The changes instituted in 2005 marked a clear departure from the previous set of 
rules. In 1995, under the leadership of Harold Varmus, the NIH instituted polices 
allowing many types of relationships between intramural scientists and the private 
sector.
15
 For example, intramural scientists could engage with the private sector and 
be paid any amount for their services including the receipt of stock (and stock 
options).
16
 The intramural scientists went through an approval process, but in many 
ways this review process was perfunctory.
17
 One of the reasons for the open nature 
of the 1995 rules may have been so that the NIH could attract and retain top 
scientists who would have otherwise gone elsewhere if they could make more 
money at another institution or in the private sector. Dr. Varmus is credited with 
recruiting top scientists and with convincing Congress to increase the NIH 
budget.
18
 
                                                                                                                 
 
 14. Summary of NIH-Specific Amendments to Conflict of Interest Ethics Regulations, 
NAT’L INSTS. HEALTH (Mar. 4, 2011), http://www.nih.gov/about/ethics/summary_amend 
ments_08252005.htm.  
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In late 2003, the L.A. Times published an exposé suggesting that the financial 
relationships between NIH scientists and the private sector created conflicts that 
negatively impacted subjects and studies.
19
 The article, Stealth Merger: Drug 
Companies and Government Medical Research, named individual NIH scientists 
and indicated the amount of money these scientists received from the private 
sector.
20
 
Congress responded to the news regarding the relationships between NIH 
scientists and the private sector by holding hearings in January 2004.
21
 At these 
hearings, the then-NIH Director, Elias Zerhouni, testified before the Congressional 
Subcommittee.
22
 In his comments, Dr. Zerhouni denied allegations that any patient 
was harmed as a result of a financial arrangement between an NIH scientist and the 
private sector.
23
 Dr. Zerhouni acknowledged that there is a “perception of 
widespread conflicts that needs to be corrected as soon as possible.”24 To address 
these concerns, Dr. Zerhouni created a Blue Ribbon Task Force to review the NIH 
policies and make recommendations on reforms.
25
 
On June 22, 2004, the Blue Ribbon Panel on Conflict of Interest Policies 
released its report.
26
 The report contained eighteen recommendations that included 
such actions as restricting consulting arrangements, restricting financial interests 
for scientists engaged in research involving human subjects, limitations on 
compensation from outside activities, and greater oversight.
27
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 24. Id. 
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In early 2005, Dr. Zerhouni announced a new set of rules, some of which were 
more restrictive than the recommendations proposed by the Blue Ribbon Panel.
28
 
The new rules include a prohibition on outside consulting with SAOs, divestiture of 
stock holdings above a specific threshold, prior approval for receipts of monetary 
awards, disclosure reports, review and prior approval for activities with 
professional and scientific organizations, and prior approval for compensated 
academic outside activities.
29
 In sum, the 2005 rules were much more restrictive 
than the previous rules. 
B. Impact of 2005 Rules on Retention and Recruitment of Scientists 
FCOI rules try to strike a delicate balance between allowing a positive public-
private interaction to exist without creating situations in which harms may occur. 
One concern that the NIH may have is how to attract and retain top scientists to the 
NIH knowing that these top scientists can make much more money in other 
capacities. Some may believe that restrictions on outside pay (e.g., from the private 
sector), may mean that top scientists will not want to work for a government 
salary.
30
 And, although this may be a concern, others argue that the type of research 
and the freedom of research offered at the NIH will more than compensate for the 
lower salary.
31
 
Due to concern over recruitment and retention of scientists from the increased 
restrictions of the 2005 rules, the NIH conducted a survey to evaluate the impact of 
the new ethics rules.
32
 The NIH consulted with an outside independent research 
organization, ORC Macro, to conduct an assessment of the impact of the 2005 
rules.
33
 The survey found that the vast majority of NIH employees were satisfied 
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slides.pdf; see also, Twombly, supra note 4, at 8. 
 33. Evaluation of the Impact of the New NIH Ethics Rules on Recruitment and 
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with their jobs (78.6%) and they intended to be working at the NIH next year 
(85.6%).
34
 More than one-third of respondents did not have a strong or basic 
understanding of the new ethics rules, despite that almost all the NIH employees 
completed the annual ethics training.
35
 More than half of those surveyed felt that 
there was a need for the NIH to address the rules governing conflicts of interest, but 
it was almost evenly split among that group as to whether that could be addressed 
by improved enforcement of the 1995 rules or whether new rules were needed.
36
 
Many respondents felt that the 2005 rules may impact the overall ability of the NIH 
to complete its mission (37.5%), to keep its status as a leader in scientific research 
(16.5%), and to recruit and retain staff (56.2% and 54.7%, respectively). 
Respondents felt that the restrictions on outside activities were most likely to 
negatively impact the NIH in the long term (37.8%) compared to restrictions on 
financial holdings, restrictions on awards, and no restrictions.
37
 More than half the 
employees responded that the new rules would have no impact on them 
personally.
38
 
A different study analyzed the impact of the 2005 ethics rules on patenting, 
publishing, collaborations, and internal perceptions.
39
 This study, conducted by 
Darren Zimmer and colleagues, employed a survey that was administered to a 
group of people within the NIH.
40
 Some respondents answered that they had 
concerns about validity of the work of an intramural scientist who had a 
relationship with industry.
41
 A larger number of respondents answered that they 
thought there would be an increase in bias and secrecy if the ethics rules were 
relaxed (32% and 42.4%, respectively).
42
 Interestingly, 84.3% of respondents 
believed that new research that was not currently being done could be done if the 
ethics rules were relaxed.
43
 In addition, almost half of the respondents believed that 
the NIH ethics rules should apply to extramural scientists in AMCs.
44
 This survey 
also demonstrated that there has been a decline in government-industry 
relationships since the implementation of the 2005 ethics rules.
45
 Furthermore, the 
study found that intramural scientists with industry relationships publish at nearly 
twice the rate as their peers (6.7 versus 3.8 articles per year).
46
 The underlying 
reason for this is unclear. It could be that the most productive scientists are those 
sought out by industry, or that the most productive scientists are more likely to 
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engage in multiple types of collaborations.
47
 Importantly, the overall rate of 
publication did not appear to decline after the implementation of the 2005 ethics 
rules.
48
 
These studies suggest a lot about the impact of the 2005 ethics rules, but they do 
not establish that the rules do not have the desired effects. For example, these 
studies suggest that overall employee retention may not be greatly impacted 
because most respondents answered that they intended to remain working at the 
NIH.
49
 This does not, however, address select big-name scientists. For example, the 
loss of five highly productive and creative scientists can have a much greater 
impact than the loss of twenty mediocre scientists.
50
 It is difficult to test for these 
types of selective losses; rather, that information is most often noted anecdotally. 
But, the studies do show that the 2005 ethics rules are not causing a mass exodus 
and that intramural scientists continue to publish at the same rate as before the 
implementation of the rules. 
The 2005 ethics rules can be analogized to a set of default rules. That is, the 
2005 rules apply to all intramural scientist-industry relationships. The application 
of a set of default rules to intramural scientists is different than the types of rules 
that apply to extramural scientists, and this Essay urges that both intramural and 
extramural scientists should be subject to the same set of rules.  
III. APPLICATION OF DEFAULT RULES TO EXTRAMURAL SCIENTISTS 
AMCs struggle to properly regulate the area of FCOIs.
51
 The cornerstone of 
current policies is disclosure.
52
  
Why should intramural scientists be subject to one set of rules while extramural 
scientists are subject to another set of rules? One answer is that they should not. 
Another answer is that the rules that apply to intramural scientists should apply to 
extramural scientists. For example, the strict rules that limit personal financial gain 
through relationships with industry as applied to intramural scientists should extend 
to extramural scientists. Studies show that even small token gifts can have an 
influence over faculty.
53
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Some AMCs and faculty will likely oppose the application of the NIH 
guidelines. One argument they could make is that the survey results, described 
above, demonstrate some negative impacts since the implementation of the rules. 
One response to this is that while there may be some collateral damage, the surveys 
indicate that employee retention remains strong and publishing rates appear steady. 
Another argument against imposing the NIH guidelines on extramural scientists 
could be that it limits the amount of income that extramural scientists stand to 
make. Most scientists, however, enter academics to enjoy the intellectual freedom 
and the ability to work with smart colleagues, and it seems unlikely that the 
academy will fall apart with strict rules that govern FCOIs. 
To address the concerns by opponents of applying the NIH rules to extramural 
scientists, the NIH could issue a call for grant applications for investigators that 
would like to study the impact of the application of the NIH guidelines to 
extramural investigators. Over a five-year period, a study could analyze what 
effect, if any, stricter rules have on retention, recruitment, publications, and morale. 
This study would be similar to the one conducted within the NIH to understand the 
impact of the NIH guidelines on intramural scientists. 
The NIH guidelines may not adequately address all of the areas in extramural 
research that are impacted by FCOIs. To address the areas that differ, the NIH can 
give special awards to AMCs that produce innovative ways to address areas that are 
not included in the NIH guidelines.  
The overall goal here is to protect scientific integrity and the public’s trust in 
scientific research. To do this, it is necessary to ensure that the profit-seeking 
motive of private industry does not unduly influence the work of intramural and 
extramural scientists. For these reasons, the strict rules that apply to intramural 
scientists should extend to extramural scientists. 
CONCLUSION 
The legal and medical scholarship is in large agreement that something needs to 
be done to address FCOIs at AMCs. Many argue that the current policy of 
disclosure is inadequate. This Essay proposes that extramural scientists, who 
receive NIH grant money, should be subject to the same FCOI rules that apply to 
intramural scientists. The NIH guidelines are more restrictive than current rules that 
apply to extramural scientists. Although there may be some pushback to the 
application of strict rules, it is worth taking the time to apply these rules and then 
study the impact to AMCs. 
